Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Microglia: An Interface between the Loss of Neuroplasticity and Depression.

Singhal G, Baune BT.

Front Cell Neurosci. 2017 Sep 8;11:270. doi: 10.3389/fncel.2017.00270. eCollection 2017. Review.

2.

Role of neural barriers in the pathogenesis and outcome of Streptococcus pneumoniae meningitis.

Prager O, Friedman A, Nebenzahl YM.

Exp Ther Med. 2017 Mar;13(3):799-809. doi: 10.3892/etm.2017.4082. Epub 2017 Jan 24.

3.

Human astrocytes in the diseased brain.

Dossi E, Vasile F, Rouach N.

Brain Res Bull. 2018 Jan;136:139-156. doi: 10.1016/j.brainresbull.2017.02.001. Epub 2017 Feb 13. Review.

4.

Venlafaxine ameliorates the depression-like behaviors and hippocampal S100B expression in a rat depression model.

Wang CH, Gu JY, Zhang XL, Dong J, Yang J, Zhang YL, Ning QF, Shan XW, Li Y.

Behav Brain Funct. 2016 Dec 8;12(1):34.

5.

Serum S100B Is Related to Illness Duration and Clinical Symptoms in Schizophrenia-A Meta-Regression Analysis.

Schümberg K, Polyakova M, Steiner J, Schroeter ML.

Front Cell Neurosci. 2016 Feb 25;10:46. doi: 10.3389/fncel.2016.00046. eCollection 2016.

6.

Depression as a Glial-Based Synaptic Dysfunction.

Rial D, Lemos C, Pinheiro H, Duarte JM, Gonçalves FQ, Real JI, Prediger RD, Gonçalves N, Gomes CA, Canas PM, Agostinho P, Cunha RA.

Front Cell Neurosci. 2016 Jan 22;9:521. doi: 10.3389/fncel.2015.00521. eCollection 2015. Review.

7.

First evidence for glial pathology in late life minor depression: S100B is increased in males with minor depression.

Polyakova M, Sander C, Arelin K, Lampe L, Luck T, Luppa M, Kratzsch J, Hoffmann KT, Riedel-Heller S, Villringer A, Schoenknecht P, Schroeter ML.

Front Cell Neurosci. 2015 Oct 9;9:406. doi: 10.3389/fncel.2015.00406. eCollection 2015.

8.

S100B Serum Levels Predict Treatment Response in Patients with Melancholic Depression.

Ambrée O, Bergink V, Grosse L, Alferink J, Drexhage HA, Rothermundt M, Arolt V, Birkenhäger TK.

Int J Neuropsychopharmacol. 2015 Sep 12;19(3):pyv103. doi: 10.1093/ijnp/pyv103.

9.

Association between environmental tobacco smoke and depression among Korean women.

Kim NH, Kim HC, Lee JY, Lee JM, Suh I.

BMJ Open. 2015 Jun 22;5(6):e007131. doi: 10.1136/bmjopen-2014-007131.

10.

Pathogenesis of depression: Insights from human and rodent studies.

Ménard C, Hodes GE, Russo SJ.

Neuroscience. 2016 May 3;321:138-162. doi: 10.1016/j.neuroscience.2015.05.053. Epub 2015 May 30. Review.

11.

Serum S100B Protein Levels in Patients with Panic Disorder: Effect of Treatment with Selective Serotonine Reuptake Inhibitors.

Cagatay Kaya B, Karadag H, Oner O, Kart A, Turkcapar MH.

Psychiatry Investig. 2015 Apr;12(2):260-2. doi: 10.4306/pi.2015.12.2.260. Epub 2014 Dec 12.

12.

S100B blood levels and childhood trauma in adolescent inpatients.

Falcone T, Janigro D, Lovell R, Simon B, Brown CA, Herrera M, Myint AM, Anand A.

J Psychiatr Res. 2015 Mar;62:14-22. doi: 10.1016/j.jpsychires.2014.12.002. Epub 2014 Dec 25.

13.
14.

Higher serum S100B and BDNF levels are correlated with a lower pressure-pain threshold in fibromyalgia.

Zanette SA, Dussan-Sarria JA, Souza A, Deitos A, Torres IL, Caumo W.

Mol Pain. 2014 Jul 8;10:46. doi: 10.1186/1744-8069-10-46.

15.

Elevated concentrations of neurofilament light chain in the cerebrospinal fluid of bipolar disorder patients.

Jakobsson J, Bjerke M, Ekman CJ, Sellgren C, Johansson AG, Zetterberg H, Blennow K, Landén M.

Neuropsychopharmacology. 2014 Sep;39(10):2349-56. doi: 10.1038/npp.2014.81. Epub 2014 Apr 3.

16.

Glutamate and its receptors in the pathophysiology and treatment of major depressive disorder.

Niciu MJ, Ionescu DF, Richards EM, Zarate CA Jr.

J Neural Transm (Vienna). 2014 Aug;121(8):907-24. doi: 10.1007/s00702-013-1130-x. Epub 2013 Dec 8. Review.

17.

Neurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidence.

Najjar S, Pearlman DM, Devinsky O, Najjar A, Zagzag D.

J Neuroinflammation. 2013 Dec 1;10:142. doi: 10.1186/1742-2094-10-142. Review.

18.

Glial abnormalities in substance use disorders and depression: does shared glutamatergic dysfunction contribute to comorbidity?

Niciu MJ, Henter ID, Sanacora G, Zarate CA Jr.

World J Biol Psychiatry. 2014 Jan;15(1):2-16. doi: 10.3109/15622975.2013.829585. Epub 2013 Sep 12. Review.

19.

Serum S100B represents a new biomarker for mood disorders.

Schroeter ML, Sacher J, Steiner J, Schoenknecht P, Mueller K.

Curr Drug Targets. 2013 Oct;14(11):1237-48. Review.

20.

Neuroinflammation and psychiatric illness.

Najjar S, Pearlman DM, Alper K, Najjar A, Devinsky O.

J Neuroinflammation. 2013 Apr 1;10:43. doi: 10.1186/1742-2094-10-43. Review.

Supplemental Content

Support Center